The claim that a Johnson & Johnson subsidiary knowingly sold faulty artificial hips for use in hip-replacement surgery has gotten lavish coverage in the Times, including a front-page news article, a news article on the front of the business section, an editorial, and a news analysis in the Sunday Review section. But when a jury rejected the claim, it merits only a short article inside the business section. A jury in another similar case had a different verdict, but at a certain point, if the courts don't agree with the editors, the readers are owed a more complete narrative that corrects the story.